sopsi         

Loading

G. Lando, E. Daneluzzo, M. Marinelli, D. Gianfelice, C. Petruzzi, A. Rossi - Vol. 8, March 2002, Issue 1

Testo Immagini Bibliografia Summary Indice

Differenze di genere nel Disturbo Ossessivo-Compulsivo nei pazienti in trattamento con fluvoxamina
Gender differences in Obsessive-Compulsive disorder in patients in treatment on fluvoxamine

1 Black DW. Epidemiology and genetics of OCD: a review and discussion of future directions for research. Int J Neuropsychiatr Med 1996;1:10-6.

2 Kaplan HI, Sadock BJ, Grebb JA. Kaplan and Sadock’s synopsis of psychiatry. Behavioural sciences, clinical psychiatry. 7th Edition. Baltimore: Williams & Wilkins 1997.

3 Rasmussen SA, Tsuang MT. The epidemiology of obsessive Compulsive disorder. J Clin Psychiatry 1984;45:450-7.

4 Rasmussen SA, Tsuang MT. Clinical characteristics and family history in DSM-III obsessive-compulsive disorder. Am J Psychiatry 1986;143:317-32.

5 Karno M, Golding JM. Obsessive-Compulsive disorder. In: Robins LN, Regier DA, eds. Psychiatric disorders in America. The epidemilogy catchment area study. London: Macmillian 1991:204-19.

6 Fischer DJ, Himle JA, Hanna LG. Age and gender effects on obsessive-compulsive symptoms in children and adults. Depression and Anxiety 1996;4:237-9.

7 Matsunaga H, Kiriike N, Matsui T, Miyata A, Iwasaki Y, Fujimoto K, et al. Gender differences in social and interpersonal features and personality disorders among japanese patients with obsessive-compulsive disorder. Compr Psychiatry 2000;41:266-72.

8 Castle DJ, Deale A, Marks IM. Gender differences in obsessive compulsive disorder. Australian and New Zealand J Psychiatry 1995;29:114-7.

9 Bogetto F, Venturello S, Albert U, Maina G, Ravizza L. Gender-related clinical differences in obsessive-compulsive disorder. Eur Psychiatry 1999;14:434-41.

10 Lensi P, Cassano B, Correddu G, Ravagli S, Kunovac JL, Akiskal HS. Obsessive-compulsive disorder. Familial-developmental history, symptomatology, comorbidity and course with special reference to gender-related differences. Br J Psychiatry 1996;169:101-7.

11 American Psychiatric Association. Diagnostic and statistical manual of mental disorders (DSM-IV) 4th ed. Washington DC: APA. 1994.

12 Goodman WK, Rasmussen SA, Price LH, Mazure C, Heninger GR, Charney DS. Yale-Brown Obsessive Compulsive Scale (Y-BOCS). Department of Psychiatry Yale University School of Medicine, Department of Psychiatry Brown University School of Medicine 1989.

13 Noshirvani HF, Kasvikis Y, Marks IM, Tsakiris F, Monteiro WO. Gender-divergent etiological factors in obsessive-compulsive disorder. Br J Psychiatry 1991;158:260-3.

14 Rubenstein CS, Pigott TA, L’Heureux F, Hill JL, Murphy LD. A preliminary investigation of the lifetime prevalence of anorexia and bulimia nervosa in patients with obsessive compulsive disorder. J Clin Psychiatry 1992;53:309-14.

15 Zohar J, Gross-Isseroff R, Hermesh H, Weizman A. Is there sexual dimorphism in obsessive-compulsive disorder? Neurosci Biobehav Rev 1999;23:845-9.

16 Biver F, Lotstra F, Monclus M, Wikler D, Damhaut P, Mendlewicz J, et al. Sex difference in 5HT2 receptor in the living human brain. Neurosci Lett 1996;2:161-8.

17 Steiner M, Lepage P, Dunn EJ. Serotonin and gender-specific psychiatric disorders. Int J Psychiatry Clin Pract 1997;1:3-13

18 Greist JH, Jenike MA, Robinson D, Rasmussen SA. Efficacy of fluvoxamine in obsessive-compulsive disorder: results of a multicentre, double blind, placebo controlled trial. Eur J Clin Res 1995;7:195-204.

19 Goodman WK, Lawrence HP, Rasmussen SA, Delgado PL, Heninger GR, Charney DS. Efficacy of fluvoxamine in obsessive-compulsive disorder. Arch Gen Psychiatry 1989;46:36-44.

20 Perse TL, Greist HJ, Jefferson JW, Rosenfeld R, Dar R. Fluvoxamine treatment of obsessive-compulsive disorder. Am J Psychiatry 1987;144:1543-8.

21 Mundo E, Bareggi SR, Pirola R, Bellodi L. Effect of acute intravenos clomipramine and antiobsessional response to proserotonergic drugs: is gender a predictive variable? Soc Biol Psychiatry 1999;45:290-4.

22 Leckman JF, Goodman WK, North WG, Chappell PB, Price LH, Pauls DL, et al. Elevated cerebrospinal fluid levels of oxytocin in obsessive-compulsive disorder. Comparison with Tourette’s syndrome and healthy controls. Arch Gen Psychiatry 1994;51:782-92.

23 Weiss M, Baerg E, Wisebord S, Temple J. The influence of gonadal hormones on periodicity of obsessive-compulsive disorders. Can J Psychiatry 1995;40:205-7.

24 Williams KE, Koran LM. Obsessive-compulsive disorder in pregnancy, the puerperium, and the premenstruum. J Clin Psychiatry 1997;58:330-6.

25 Altemus M, Jacobson KR, Debellis M, Kling M, Pigott T, Murphy DL, et al. Normal CSF oxytocin and NPY levels in OCD. Biol Psychiatry 1999;45:931-3.

26 Zhang L, Ma W, Barker JL, Rubinow DR. Sex differences in expression of serotonin receptors (subtypes 1A and 2A) in rat brain: a possible role of testosterone. Neurosci 1999;94:251-9.